^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    atlacabtagene autoleucel (WZTL-002)

    i
    Other names: autologous third-generation anti-CD19 chimeric antigen receptor T-cells, WZTL002, Atla-cel, WZTL-002, WZTL002-1, 1928T2z CAR-T cells, WZTL 002
    Associations
    News
    Trials
    Company:
    BioOra, Wellington Zhaotai Therapies
    Drug class:
    CD19-targeted CAR-T immunotherapy, CD28 modulator, CD3 modulator
    Related drugs:
    Associations
    News
    Trials